Research area
Parkinson's Disease clinical trials
Investigational medications, devices, and exercise or therapy programs for movement and non-movement symptoms are what Parkinson's disease studies examine. With CNS Clinical Research, you can find out whether one of those studies may be a fit for you.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Parkinson's disease studies in numbers
- Parkinson's disease studies recruiting in the U.S.
- 247
- states with a study site
- 50
- studies that accept healthy volunteers
- 56
Source: ClinicalTrials.gov. Data processed .
Find Parkinson's disease studies by state
These states have the most studies recruiting right now.
Florida
52 studies recruiting.
California
49 studies recruiting.
New York
42 studies recruiting.
Texas
40 studies recruiting.
Ohio
34 studies recruiting.
Pennsylvania
31 studies recruiting.
Parkinson's disease studies recruiting now
As of November 16, 2026, 247 Parkinson's disease studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.
What they test
- medications72
- devices68
- other approaches42
- behavioral approaches such as talk therapy or training33
- biologics such as vaccines or antibodies18
A study can test more than one.
Main purpose
- treating a condition121
- basic science31
- diagnosis19
- other purposes8
Phase
- Early Phase 110
- Phase 117
- Phase 1/214
- Phase 227
- Phase 2/32
- Phase 311
- Phase 49
- No phase103
- Observational54
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other175
- industry58
- government14
Who they enroll
- adults (18 to 64)247
- older adults (65 and over)246
- children (under 18)17
56 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 247 studies.
Recently updated Parkinson's disease studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Recruiting in
- Ann Arbor, MI · Arlington Heights, IL · Austin, TX · and 39 more U.S. locations
- Registry record
- NCT06989112 · updated
Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
- Phase 1
- Ages 18 to 80
- All sexes
- Sponsor
- University of Alabama at Birmingham
- Recruiting in
- Birmingham, AL
- Registry record
- NCT07557706 · updated
Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
- Phase 2
- Ages 40 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Boca Raton, FL
- Registry record
- NCT07781644 · updated
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- East Syracuse, NY · Grand Rapids, MI · Houston, TX · and 3 more U.S. locations
- Registry record
- NCT06469944 · updated
Neocortical Microarchitecture of Executive Function
- No phase
- Ages 45 to 85
- All sexes
- Sponsor
- University of Colorado, Denver
- Recruiting in
- Aurora, CO
- Registry record
- NCT06778135 · updated
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Phase 1/2
- Ages 45 and older
- All sexes
- Sponsor
- Prabesh Kanel
- Recruiting in
- Ann Arbor, MI
- Registry record
- NCT07154511 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in the United States on ClinicalTrials.gov.
What Parkinson's disease studies look at
Studies of Parkinson's disease look at investigational medications, devices, and exercise or therapy programs aimed at movement and non-movement symptoms. Every study is built around one specific question. That is why the things you would be asked to do change from one study to the next.
Whatever a study is testing is investigational. Researchers are still learning how well it works and what risks it carries, and that is exactly why the study is being run.
Who may be able to take part
Each Parkinson's disease study sets requirements of its own. Your age, your health history, the medications you currently take, and the effect Parkinson's disease has on you can all be part of them. Some studies also take volunteers who do not have Parkinson's disease at all.
Sorting out whether you fit is not your job. The study team does that check with you at a screening visit. Read how eligibility and screening work.
What taking part usually involves
A first conversation
Before anything else happens, a coordinator walks you through the study in general terms and answers the questions you have.
Informed consent
The study team hands you a written explanation covering every detail of the study, and it spells out the risks that are known. Whether you agree is your call.
Screening
You answer questions about your health and have tests, and the results show if this study fits you. Being screened does not always lead to taking part.
Study visits
Should you decide to join a Parkinson's disease study, you come in for planned appointments, and those give the study team a way to follow your health. Taking part stays voluntary. You can stop whenever you choose.
Questions about Parkinson's disease studies
Do I need a diagnosis to join a study about Parkinson's disease?
Each study handles this differently. For some, you must already have a confirmed diagnosis. For others, the assessment happens at screening. Which rule applies to you is something the study team will explain.
Would I have to change the care I receive now?
Keep your current care as it is and do not change anything on your own. Whether current care can continue depends on the study: some allow it and others do not. The study doctor goes over this with you, and you can discuss it with your own doctor before you decide.
Is there a cost to take part?
As a participant, you generally do not pay for study visits, study tests, or the study medication. Read more about costs.
Ask about Parkinson's disease studies
Send a few details and a coordinator will follow up with you. Making an enquiry carries no obligation, so you stay free to say no.
Independent information
- Parkinson's Disease — National Institute of Neurological Disorders and Stroke (NIH)
- Clinical Trials — MedlinePlus (National Library of Medicine)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)